Lipid levels in human saliva were found to be significantly linked to complications related to cystic fibrosis (CF) —…
Articles by Steve Bryson, PhD
CFTR modulators, approved therapies to treat cystic fibrosis (CF), showed antibacterial activity and enhanced the efficacy of some antibiotics…
Treatment with Trikafta improved insulin secretion and body weight within one year in people with cystic fibrosis (CF),…
Researchers have discovered that monocytes, a type of white blood cell, drive persistent and sustained inflammation that leads to lung…
Enrollment of adults at sites across the U.S. is continuing for a Phase 2a trial of AR-501 (gallium citrate),…
The incidence of colorectal cancer (CRC) in people with cystic fibrosis (CF) was five times higher than in those…
Newborn genetic screening panels for variants in the CFTR gene — mutations of which are the underlying cause of…
Trikafta (elexacaftor, tezacaftor, and ivacaftor) was found to successfully lessen the microbial load in the airways of people with…
A new study suggests that the use of anti-inflammatory medications to modulate immune signaling proteins in people with cystic…
Higher weight in children with cystic fibrosis (CF) at 1 year of age, and increasing weight gain from ages…